The partial volume effect in the quantification of 1H magnetic resonance spectroscopy in Alzheimer's disease and aging
Ver/ abrir
Use este enlace para citar
http://hdl.handle.net/2183/19468Coleccións
- GI-RNASA - Artigos [195]
Metadatos
Mostrar o rexistro completo do ítemTítulo
The partial volume effect in the quantification of 1H magnetic resonance spectroscopy in Alzheimer's disease and agingAutor(es)
Data
2014Cita bibliográfica
Mato Abad V, Quirós A, García-Álvarez R, et al. The partial volume effect in the quantification of 1H magnetic resonance spectroscopy in Alzheimer's disease and aging. J Alheimer Dis. 2014;42(3):801-811
Resumo
[Abstract] 1H-MRS variability increases due to normal aging and also as a result of atrophy in grey and white matter caused by neurodegeneration. In this work, an automatic process was developed to integrate data from spectra and high-resolution anatomical images to quantify metabolites, taking into account tissue partial volumes within the voxel of interest avoiding additional spectra acquisitions required for partial volume correction. To evaluate this method, we use a cohort of 135 subjects (47 male and 88 female, aged between 57 and 99 years) classified into 4 groups: 38 healthy participants, 20 amnesic mild cognitive impairment patients, 22 multi-domain mild cognitive impairment patients, and 55 Alzheimer's disease patients. Our findings suggest that knowing the voxel composition of white and grey matter and cerebrospinal fluid is necessary to avoid partial volume variations in a single-voxel study and to decrease part of the variability found in metabolites quantification, particularly in those studies involving elder patients and neurodegenerative diseases. The proposed method facilitates the use of 1H-MRS techniques in statistical studies in Alzheimer's disease, because it provides more accurate quantitative measurements, reduces the inter-subject variability, and improves statistical results when performing group comparisons.
Palabras chave
Alzheimer’s disease
Dementia
Magnetic resonance imaging
Magnetic resonance spectroscopy
Mild cognitive impairment
Myoinositol
N-acetylaspartate
Dementia
Magnetic resonance imaging
Magnetic resonance spectroscopy
Mild cognitive impairment
Myoinositol
N-acetylaspartate
Versión do editor
Dereitos
The final publication is avaliable at IOS Press Content Library
ISSN
1387-2877
1875-8908
1875-8908